despit
advanc
medic
scienc
threat
pose
virus
remain
seriou
problem
particularli
outsid
industri
countri
human
immunodefici
viru
hiv
hepat
b
c
virus
hbv
hcv
continu
claim
million
live
everi
year
virus
like
sar
coronaviru
appear
human
pathogen
novel
variant
wellknown
virus
like
influenza
viru
caus
pandem
global
dimens
thu
press
unmet
medic
need
develop
new
antivir
drug
small
molecul
domin
antivir
decad
biolog
like
monoclon
antibodi
nucleic
acid
therapi
recent
consid
promis
altern
among
variou
oligonucleotidebas
strategi
rna
interfer
rnai
wide
regard
particularli
power
technolog
rnai
posttranscript
gene
silenc
mechan
trigger
doublestrand
rna
applic
mammalian
cell
small
interf
rna
sirna
approxim
base
pair
two
nucleotid
overhang
end
strand
becom
incorpor
rnainduc
silenc
complex
risc
induc
cleavag
complementari
target
rna
within
year
rnai
becom
standard
molecular
biolog
method
studi
gene
function
moreov
technolog
develop
new
therapeut
approach
approxim
dozen
clinic
trial
base
rnai
current
underway
among
trial
variou
applic
rnai
treat
infect
respiratori
syncyti
viru
hbv
hiv
silenc
endogen
express
gene
becom
routin
procedur
predesign
valid
sirna
silenc
guarante
virtual
human
murin
gene
commerci
avail
contrast
design
sirna
high
antivir
activ
still
remain
challeng
task
sever
featur
describ
influenc
success
rnai
approach
thermodynam
design
sirnastructur
sirna
antisens
strandstructur
target
rna
public
avail
tool
design
sirna
exclus
optim
base
composit
sirna
recent
howev
design
algorithm
develop
select
sirna
particularli
high
potenc
specif
focus
design
sirna
also
take
consider
secondari
structur
sirna
target
site
major
challeng
longterm
inhibit
virus
rnai
prevent
viral
escap
thu
sirna
need
direct
wellconserv
target
site
unfortun
simpli
direct
sirna
protein
code
region
insuffici
sinc
silent
mutat
caus
sirna
lose
inhibitori
potenti
target
region
import
function
structur
rna
may
prove
better
choic
avoid
viral
escap
exampl
shown
sirna
highli
conserv
cisact
replic
element
cre
capabl
inhibit
variou
enterovirus
long
period
sirna
target
proteinencod
region
rna
organ
function
three
dimension
structur
led
rapid
viral
escap
sinc
even
care
select
singl
target
site
might
insuffici
sustain
viral
silenc
use
multipl
sirna
multipl
target
site
may
necessari
prevent
viral
escap
case
coxsackieviru
resist
rapidli
emerg
singl
molecul
use
combin
three
four
sirna
respect
target
distinct
region
genom
abl
prevent
emerg
resist
gener
requir
applic
rnai
vivo
stabil
sirna
introduct
modifi
nucleotid
base
experi
antisens
field
numer
modifi
nucleotid
assess
applic
enhanc
stabil
sirna
nucleas
phosphorothio
nucleotid
modif
posit
eg
well
lock
nucleic
acid
among
wide
employ
build
block
rnai
applic
fulli
modifi
sirna
drastic
increas
halflif
human
serum
significantli
higher
activ
vectorbas
vivo
model
hbv
infect
compar
unmodifi
form
furthermor
introduct
modifi
nucleotid
improv
stabil
sirna
also
reduc
offtarget
effect
improv
antivir
activ
sirna
direct
highli
structur
target
region
present
chapter
describ
systemat
method
design
highli
potent
antivir
sirna
summar
fig
experiment
procedur
test
sirna
report
assay
gfp
report
assay
dualluciferas
report
assay
well
assay
infecti
virus
cell
viabil
assay
plaqu
reduct
assay
outlin
final
option
improv
properti
sirna
introduct
modifi
nucleotid
describ
ct
ntgfp
fusion
topo
ta
express
kit
invitrogen
carlsbad
ca
usa
store
compet
cell
compon
kit
isol
viral
dna
rna
recommend
use
commerci
isol
kit
exampl
high
pure
viral
nucleic
acid
kit
roch
diagnost
mannheim
germani
materi
revers
transcript
genom
isol
viru
rnamateri
pcr
taq
polymeras
polymeras
proofread
activ
use
pcrmateri
gel
purif
dna
recommend
use
commerci
avail
gel
purif
kit
exampl
nucleospin
extract
ii
machereynagel
germani
lb
medium
dilut
wv
trypton
wv
nacl
wv
yeast
extract
autoclav
steril
lb
agar
plate
addit
contain
wv
agar
select
add
ampicillin
store
lb
medium
lb
agar
plate
warm
room
temperatur
usemateri
isol
plasmid
dna
testrestrict
sequenc
dna
plasmid
miniprep
kit
suffici
transfectiongrad
plasmid
recommend
use
commerci
avail
plasmid
dna
isol
kit
exampl
nucleobond
xtra
midi
kit
machereynagel
primer
sequenc
forward
tac
gac
tca
cta
tag
gfp
revers
revers
taa
gct
ttc
cgt
atg
tag
sequenc
gfp
forward
forward
cac
aat
ctg
ccc
ttt
bgh
revers
revers
aag
gca
cag
tcg
vector
promega
madison
wi
usa
store
materi
describ
gfp
report
assay
see
subhead
except
item
enzym
xho
recommend
use
commerci
avail
restrict
enzym
optim
buffer
dna
ligas
recommend
use
commerci
dna
ligat
kit
correspond
bufferprim
sequenc
vector
revers
primer
att
tag
atc
ctc
aca
phosphatebuff
salt
solut
pb
without
ca
mg
paa
laboratori
gmbh
germani
dualluciferas
report
assay
system
promega
store
compon
kit
longterm
storag
prepar
aliquot
store
dulbecco
modifi
eagl
medium
dmem
paa
laboratori
supplement
fetal
calf
serum
fc
paa
mm
glutamin
nonessenti
amino
acidsdulbecco
pb
without
ca
mg
paa
laboratori
optimem
invitrogen
serumfre
dmemlipofectamin
transfect
reagent
invitrogen
store
microscop
gfp
filter
addit
filter
transfect
effici
sirna
cell
line
test
dulbecco
pb
without
ca
mg
paa
dtt
lysi
buffer
mm
ph
wv
sd
mm
dtt
vv
glycerol
wv
bromophenol
blue
store
aliquot
salin
tb
mm
tri
mm
nacl
ph
prepar
tenfold
stock
solut
contain
mm
tri
mm
nacl
adjust
ph
hcl
store
room
temperatur
tb
dilut
stock
solut
prepar
solut
contain
tb
tween
store
room
temperaturemateri
standard
western
blot
includ
hybondp
pvdf
membran
amershamg
healthcar
uppsala
sweden
nonfat
dri
milk
powderponceau
solut
ponceau
acet
acid
water
store
room
temperatureprimari
antibodi
polyclon
antigfp
rabbit
serum
invitrogen
store
use
dilut
western
blot
mous
monoclon
antiactin
antibodi
chemiconmillipor
store
use
dilut
western
blotsecondari
antibodi
immuno
pure
goat
antirabbit
igg
h
l
peroxidas
conjug
pierc
part
thermo
fisher
scientif
rockford
il
usa
immuno
pure
goat
antimous
igg
h
l
peroxidas
conjug
pierc
store
western
blot
substrat
pierc
chemiluminesc
imag
materi
wet
develop
inclus
xray
film
materi
sirna
transfect
see
subhead
item
viru
stock
interestcel
prolifer
kit
ii
xtt
roch
diagnost
store
xtt
label
reagent
electroncoupl
reagent
small
aliquot
protect
lightelisa
plate
reader
measur
absorb
defin
wavelength
nm
refer
wavelength
greater
nm
materi
sirna
transfect
see
subhead
item
viru
stock
interestdifco
agar
nobl
becton
dickinson
franklin
lake
nj
usa
eagl
mem
dilut
g
minimum
essenti
medium
mem
powder
invitrogen
g
ml
water
add
antibiot
penicillin
streptomycin
steril
filtrat
filter
store
red
solut
dilut
g
neutral
red
merck
ml
pb
filter
remov
undissolv
particl
avoid
expos
solut
light
longer
necessari
dilut
prepar
freshli
first
major
step
design
highli
activ
sirna
consist
select
sirna
sequenc
favor
thermodynam
featur
thermal
stabil
end
well
base
prefer
activ
sirna
certain
posit
influenc
silenc
effici
sirna
design
sirna
public
avail
web
tool
use
exampl
given
tabl
advis
gener
sirna
pool
least
two
differ
web
tool
blast
option
appli
avoid
unspecif
bind
endogen
target
sequenc
therebi
reduc
offtarget
effect
exampl
sirna
predesign
use
rnai
design
invitrogen
describ
go
rnai
design
websit
invitrogen
see
tabl
choos
sirna
target
design
option
enter
complet
partial
target
sequenc
use
highli
conserv
region
viru
see
note
deselect
option
target
region
select
orf
utr
select
blast
databas
eg
human
virus
target
choos
human
avoid
target
site
within
human
genom
initi
test
anim
model
homolog
anim
genom
avoid
well
gc
content
set
minimum
maximum
select
default
motif
pattern
see
note
submit
press
rnai
design
button
summari
design
sirna
given
new
window
sort
output
choos
rankingselect
sirna
star
copi
sequencesin
gener
choos
best
sirna
obtain
design
tool
sirna
design
tool
includ
blast
option
ncbi
blast
follow
see
note
obtain
sirna
pool
subsequ
filter
respect
thermodynam
featur
convert
sequenc
obtain
antisens
strand
sirna
orient
antisens
strand
complementari
target
rna
see
fig
remov
duplic
sirna
ident
sirna
sequenc
exclud
sinc
singl
nucleotid
shift
sometim
influenc
effici
sirnacalcul
score
sirna
base
score
system
given
tabl
exclud
sirna
less
point
reynold
criteria
second
major
step
exclud
sirna
whose
antisens
strand
predict
form
secondari
structur
end
chang
gibb
free
energi
sirna
antisens
strand
determin
neg
valu
indic
stabl
structur
wherea
posit
valu
indic
instabl
secondari
structur
result
high
degre
unfold
singlestrand
rna
determin
use
public
avail
unafold
softwar
describ
softwar
extend
replac
mfold
softwar
zuker
go
renssela
bioinformat
web
server
see
tabl
use
dinamelt
web
serverselect
applic
nucleic
acid
quikfoldent
sirna
antisens
strand
sequenc
obtain
first
select
step
thermodynam
design
sirna
step
separ
semicolonschoos
rna
energi
rule
field
rna
fold
fix
temperatur
hybrid
temperatur
modifi
use
rna
addit
sequenc
type
specifi
linear
set
window
necessari
submit
dinamelt
server
summari
potenti
fold
result
given
new
window
see
note
exclud
sirna
whose
antisens
strand
predict
form
secondari
structur
indic
least
one
structur
neg
valu
structur
valu
around
zero
fold
probabl
analyz
see
note
access
target
rna
sequenc
consid
third
major
step
sirna
design
procedur
consist
two
step
first
fold
entir
target
rna
molecul
second
determin
chang
gibb
free
energi
local
rna
target
site
determin
use
public
avail
softwar
use
preferenti
long
rna
sequenc
subsequ
describ
go
renssela
bioinformat
web
server
see
tabl
use
mfold
web
serverselect
applic
rnafoldent
name
sequenc
foldedchoos
rna
sequenc
linear
fold
temperatur
fix
temperatur
modifi
use
rna
mfold
version
server
upper
bond
number
comput
fold
limit
less
long
sequenc
may
increas
comput
load
result
respons
time
set
window
necessarysequ
shorter
base
fold
immedi
march
longer
rna
sequenc
base
select
batch
enter
email
addresssubmit
entri
press
fold
rna
buttonrna
sequenc
longer
base
fold
altern
burnet
institut
mfold
server
see
tabl
applic
submit
rna
sequenc
base
mfold
version
paramet
window
set
accord
mfold
version
describ
except
fold
temperatur
fix
addit
limit
upper
bond
number
comput
fold
renssela
bioinformat
web
server
burnet
institut
mfold
server
give
summari
potenti
fold
calcul
number
potenti
secondari
structur
list
structur
beneath
view
individu
structur
neg
stabl
secondari
structur
go
also
indic
higher
chanc
presenc
biolog
systemsav
least
ten
structur
use
download
fold
buttonfind
correspond
target
structur
sirna
everi
potenti
foldingselect
promis
sirna
target
site
check
follow
point
number
ident
similar
target
site
program
give
variou
structur
correspond
energi
good
target
access
differ
structur
predict
increas
possibl
overal
target
access
ii
number
bond
high
number
bond
base
pair
within
target
sequenc
indic
strong
secondari
structur
less
access
sirna
determin
valu
local
rna
target
structur
select
sirna
target
site
find
correspond
sirna
target
site
determin
base
within
target
site
involv
form
secondari
structur
add
also
base
base
pair
part
close
neighborhood
exampl
base
form
loop
even
part
sirna
target
site
ii
go
thermodynam
detail
chosen
structur
output
window
fold
result
iii
find
correspond
base
mark
number
add
singl
valu
involv
base
energi
helic
loop
includ
one
base
structur
part
target
site
calcul
result
approxim
local
usual
suffici
precis
calcul
local
necessari
pleas
refer
turner
energi
rule
tabl
iv
calcul
chang
gibb
free
energi
local
rna
target
structur
local
exclud
sirna
whose
target
structur
show
strong
variabl
base
least
ten
fold
structur
differ
target
structur
furthermor
access
target
site
character
low
local
valu
therefor
select
sirna
order
local
valu
threshold
kcalmol
select
sirna
potenti
effici
sirna
silenc
effici
test
report
assay
see
subhead
note
protocol
topo
clone
describ
follow
section
shorten
version
instruct
manual
see
note
topo
clone
allow
ligat
pcramplifi
target
sequenc
viru
either
term
ct
nt
indic
gfp
express
fuse
respect
cterminu
nterminu
target
sequenc
isol
viru
dna
rna
use
commerci
dna
rna
viru
isol
kitperform
revers
transcript
reaction
isol
viru
contain
rna
genomedesign
primer
topo
clone
add
phosphat
pcr
primer
contain
atg
initi
codon
pcr
product
must
therefor
clone
frame
gfp
target
sequenc
amplifi
lack
atg
initi
codon
kozak
consensu
sequenc
kozak
consensu
sequenc
g
nnatgg
n
base
need
incorpor
forward
primer
pcr
product
may
also
clone
frame
gfp
essenti
translat
stop
codon
introduc
upstream
viru
target
sequenc
observ
improv
gfp
express
use
modifi
report
plasmid
viral
target
sequenc
part
untransl
region
gfp
report
stop
codon
incorpor
forward
primer
exampl
nnn
pcr
amplifi
target
cdna
sequencegelpurifi
dna
fragment
interest
partial
viru
cdna
target
sequenc
add
taq
dna
polymeras
buffer
mm
datp
u
taq
dna
polymeras
gelpurifi
dna
fragment
see
note
incub
min
vial
iceadd
salt
solut
topo
vector
pcr
product
set
topo
clone
reaction
see
note
mix
gentli
incub
min
room
temperatureplac
tube
ice
store
sampl
later
use
proceed
directli
transformationthaw
tube
contain
chemic
compet
escherichia
coli
cell
altern
use
cell
provid
gfp
fusion
topo
ta
express
kit
see
note
add
topo
clone
reaction
ligat
reaction
tube
contain
chemic
compet
e
coli
cell
mix
gentli
mix
pipet
downplac
tube
ice
incub
minheatshock
e
coli
cell
without
shakingtransf
tube
ice
incub
minadd
room
temperatur
lb
medium
without
antibioticscap
tube
tightli
shake
tube
horizont
minsedi
transform
e
coli
cell
centrifug
g
min
discard
supernatantresuspend
e
coli
cell
residu
lb
mediumspread
transform
prewarm
select
plate
contain
antibiot
ampicillin
incub
overnight
ten
coloniescultur
coloni
overnight
ml
lb
medium
contain
ampicillinisol
plasmid
dna
gener
low
amount
puriti
suffici
restrict
analysi
andor
sequencingto
verifi
orient
insert
analyz
plasmid
restrict
analysi
end
advantag
use
least
one
restrict
site
locat
within
viru
target
sequenc
one
present
vector
see
note
clone
contain
insert
correct
orient
sequenc
confirm
origin
sequenc
mutat
see
subhead
item
cultur
clone
choic
ml
lb
medium
contain
ampicillinisol
plasmid
dna
plasmid
dna
transfect
eukaryot
cell
must
clean
free
phenol
sodium
chlorid
prevent
cell
death
avoid
low
transfect
effici
dualluciferas
report
assay
method
measur
activ
firefli
renilla
luciferas
one
sampl
viru
target
sequenc
clone
untransl
region
renilla
luciferas
gene
infram
clone
requir
translat
stop
codon
renilla
luciferas
present
vector
clone
viru
target
sequenc
vector
subsequ
describ
firefli
luciferas
also
express
vector
allow
normal
renilla
luciferas
activ
isol
viru
dna
rna
use
commerci
avail
dna
rna
viru
isol
kitperform
revers
transcript
reaction
isol
viru
base
rnaa
infram
clone
renilla
luciferas
gene
requir
design
pcr
primer
follow
common
rule
primer
contain
one
restrict
site
use
clone
vector
see
note
exampl
use
forward
primer
ccg
ctc
gag
nnn
nnn
nnn
nnn
nnn
primer
ata
gtt
ta
g
cgg
ccg
c
nnn
nnn
nnn
nnn
nnn
enzym
recognit
site
xho
forward
primer
revers
primer
indic
upper
case
letter
lower
case
letter
show
addit
nucleotid
effici
restrict
site
locat
end
pcr
fragment
base
part
viral
target
sequenc
indic
nnn
pcr
amplifi
target
cdna
dna
fragment
interest
partial
viru
cdna
target
sequenc
prepar
analyt
gel
estim
dna
u
xho
enzym
restrict
site
use
per
dna
complement
reaction
buffer
h
restrict
enzym
incub
tube
dna
fragment
vector
previous
digest
xho
use
standard
ligat
reaction
e
coli
cell
analyz
coloni
describ
subhead
step
contain
insert
correct
orient
sequenc
see
subhead
item
first
function
assay
sirna
report
assay
advis
use
cell
line
also
employ
viru
assay
exampl
protocol
transient
transfect
hela
cell
plate
use
lipofectamin
transfect
reagent
describ
see
note
transfect
effici
cell
line
test
transfect
random
sirna
label
end
sirna
sens
strand
sirna
transfect
without
report
plasmid
recommend
use
fitc
distinguish
gfp
fluoresc
microscopi
seed
hela
cell
per
well
volum
medium
without
antibioticsincub
overnight
report
plasmid
insert
viru
target
sequenc
nm
sirna
design
antivir
sirna
neg
control
sirna
match
either
viral
target
organ
genom
optimem
serumfre
medium
total
volum
molar
concentr
relat
final
volum
lipofectamin
transfect
reagent
optimemincub
min
room
temperaturecombin
lipofectamin
dnasirna
mixtur
incub
least
minadd
final
mix
cell
remov
cultur
mediumincub
overnight
remov
medium
cultur
cellswash
cell
pbsremov
pb
aspirationadd
dtt
lysi
buffer
per
well
transfer
lysat
eppendorf
tubeboil
lysat
min
protein
wv
sdspolyacrylamid
gel
see
note
transfer
protein
pvdf
membran
use
method
choicecontrol
protein
transfer
ponceau
stain
strip
membran
wash
tbsshake
membran
follow
wash
step
antiserum
incubationsrins
membran
ttbsblock
nonfat
milk
powder
ttb
h
room
temperaturerins
membran
time
ttbswash
time
min
ttbsincub
gfp
antiserum
dilut
ttb
h
room
temperatur
overnight
membran
time
ttbswash
time
min
ttbsincub
secondari
goat
antirabbit
antibodi
conjug
horseradish
peroxidas
dilut
ttb
h
room
temperatur
overnight
membran
time
ttbswash
time
min
ttbscombin
compon
ecl
western
blot
substrat
transfer
mixtur
membraneincub
min
darkdetect
signal
use
method
choic
imag
develop
use
xray
film
strip
membran
wash
time
min
ttbsblock
nonfat
milk
powder
ttb
h
nonfat
milk
powder
ttb
min
room
temperatureto
confirm
equal
load
sampl
reprob
membran
antibodi
direct
housekeep
gene
exampl
actin
repeat
step
start
step
use
mous
monoclon
antiactin
antibodi
dilut
remov
growth
medium
cultur
cellswash
cell
pbsremov
pb
aspirationadd
passiv
lysi
buffer
plb
per
well
shake
cultur
plate
gentli
orbit
shaker
rock
platform
min
room
temperatur
cultur
plate
store
later
use
analyz
directlytransf
lysat
tube
sediment
residu
cell
debri
centrifug
full
speed
tabletop
centrifug
transfer
clear
lysat
fresh
tube
subsequ
measurementthaw
adequ
aliquot
larii
reagent
see
note
prepar
adequ
amount
stop
glo
reagent
reagent
per
measur
need
stop
glo
substrat
suppli
concentr
dilut
volum
stop
glo
substrat
volum
stop
glo
buffer
protect
reagent
light
keep
compon
room
temperatur
measurementprogram
luminomet
default
paramet
premeasur
delay
measur
period
report
pipett
larii
reagent
luminomet
tubeadd
sampl
plb
lysat
dilut
sampl
mix
gentlymeasur
activ
firefli
luciferaseadd
stop
glo
reagent
mix
gentlymeasur
activ
renilla
luciferaserepeat
measur
sampl
start
step
select
effici
sirna
follow
function
analysi
viru
assay
highli
potent
antivir
sirna
reduc
gfp
express
virtual
complet
western
blot
show
least
inhibit
renilla
luciferas
dualluciferas
report
assay
xttbase
cell
viabil
assay
use
quantif
cell
prolifer
viabil
metabol
activ
cell
cleav
yellow
tetrazolium
salt
orang
formazan
dye
absorb
measur
defin
wavelength
directli
correl
cell
viabil
recommend
use
xtt
reagent
due
high
sensit
compar
tetrazolium
salt
mtt
seed
hela
cell
per
well
volum
medium
without
antibiot
well
plateincub
overnight
follow
sirna
transfect
mixtur
quadruplicatedilut
sirna
design
antivir
sirna
neg
control
sirna
match
either
viral
target
organ
genom
optimem
serumfre
medium
volum
molar
concentr
relat
final
volum
lipofectamin
transfect
reagent
optimemincub
min
room
temperaturecombin
lipofectamin
sirna
incub
least
minadd
final
mix
per
well
cellsincub
h
see
note
calcul
amount
viru
requir
reach
specif
multipl
infect
moi
base
titer
viru
stock
number
seed
cell
dilut
viru
suspens
specif
moi
infect
use
moi
subsequ
describ
see
note
exampl
viru
titer
plaqu
form
unit
pfu
ml
per
well
viru
suspens
ad
cell
titer
pfu
per
well
valu
divid
number
seed
cell
result
absolut
moi
valu
final
dilut
factor
calcul
divid
desir
moiprepar
dilut
viru
suspens
refrigeratorcold
serumfre
medium
without
antibiot
see
note
incub
min
ad
cell
viru
dilut
store
sever
minut
necessaryadd
per
well
dilut
viru
suspens
includ
neg
control
well
remain
uninfect
end
use
serumfre
medium
without
antibiot
handl
cell
ident
infect
cellsincub
min
see
note
remov
viru
suspens
add
medium
contain
fc
antibioticsincub
begin
cell
viabil
assay
xtt
measur
prepar
adequ
amount
xtt
reagent
exampl
mix
electroncoupl
reagent
ml
xtt
label
reagentadd
per
well
fresh
xtt
reagent
incub
h
remov
mediummeasur
absorb
microtit
plate
reader
defin
wavelength
nm
refer
wavelength
greater
nm
gener
plaqu
origin
viral
infect
singl
cell
reduct
viru
titer
show
directli
effici
sirna
viru
spread
prevent
seed
hela
cell
per
well
volum
medium
without
antibiot
well
plateincub
overnight
sirna
design
antivir
sirna
neg
control
sirna
match
either
viral
target
organ
genom
optimem
serumfre
medium
volum
molar
concentr
relat
final
volum
mani
sirna
transfect
well
need
titrat
differ
viru
dilut
includ
posit
control
well
remain
untransfect
infect
differ
viru
dilutionspremix
lipofectamin
transfect
reagent
optimemincub
min
room
temperaturecombin
lipofectamin
sirna
incub
least
minadd
final
mix
per
well
cellsincub
least
h
see
note
cell
close
confluent
overlay
infect
cell
monolayerprepar
serial
dilut
viru
stock
refrigeratorcold
serumfre
medium
without
antibiot
see
note
gener
appropri
rang
dilut
depend
titer
viru
stock
incub
min
ad
cell
viru
dilut
store
sever
minut
necessaryadd
per
well
dilut
viru
suspens
includ
neg
control
well
remain
uninfect
end
use
serumfre
medium
without
antibiot
handl
cell
ident
infect
cellsincub
min
see
note
remov
viru
suspens
gentl
aspirationadd
ml
fc
ml
eaglemem
prewarm
g
difco
agar
nobl
ml
cool
add
prewarm
eaglemem
agar
nobl
solutionincub
min
make
agar
nobl
solut
eagl
overlay
use
overlay
infect
cell
monolayeradd
per
well
eagl
overlay
leav
plate
min
room
temperatur
take
care
dislodg
cellsincub
plaqu
visibl
within
around
day
depend
virusadd
neutral
red
solut
well
incub
h
see
note
remov
stain
gentl
aspirationinvert
plate
count
plaqu
wellcalcul
viral
titer
well
documentclass
minim
usepackag
amsmath
usepackag
wasysym
usepackag
amsfont
usepackag
amssymb
usepackag
amsbsi
usepackag
mathrsf
usepackag
upgreek
setlength
oddsidemargin
begin
document
begin
array
l
text
pfuml
text
count
text
plaqu
text
dilut
text
factor
time
text
volum
text
text
dilut
text
viru
text
ad
text
text
text
well
end
array
end
document
altern
protocol
use
acceler
stain
see
note
effici
sirna
abl
reduc
viru
titer
least
one
order
magnitud
figur
show
exampl
plaqu
reduct
assay
select
antivir
sirna
show
high
effici
may
chemic
modifi
decreas
potenti
offtarget
effect
andor
enhanc
serum
stabil
one
approach
reduc
offtarget
effect
prevent
incorpor
unwant
sens
strand
risc
exampl
achiev
lna
modif
end
introduct
modif
posit
sens
strand
howev
specif
reduct
offtarget
effect
observ
posit
antisens
strand
addit
modifi
theori
chemic
modif
sirna
also
result
increas
serum
stabil
practic
sirna
modif
often
accompani
decreas
silenc
effici
compar
unmodifi
sirna
lna
modif
introduc
posit
except
antisens
strand
caus
substanti
loss
silenc
effici
anoth
way
combin
high
silenc
effici
increas
serum
stabil
reduc
offtarget
effect
complet
modif
differ
nucleotid
analog
shown
sirna
target
hbv
genom
fig
howev
chemic
modif
depend
applic
well
viru
inhibit
strategi
describ
possibl
identifi
effici
sirna
virtual
given
viru
recent
exemplifi
echoviru
next
step
transfer
antivir
rnai
approach
vivo
model
one
main
challeng
effici
deliveri
sirna
desir
target
tissu
follow
chapter
describ
virusbas
approach
deliv
shrna
express
cassett
well
differ
strategi
applic
chemic
presynthes
sirna
order
identifi
conserv
region
viral
genom
advis
select
sequenc
variou
strain
perform
blast
search
region
high
homolog
consid
conserv
repres
suitabl
sirna
target
sitestuschl
motif
pattern
strongli
restrict
number
sirna
subsequ
select
may
becom
problem
short
sequenc
targetedth
ncbi
blast
tool
orand
ensembl
blast
tool
use
homolog
search
see
tabl
summari
potenti
fold
fold
possibl
andor
softwar
arei
show
term
rna
sequenc
form
secondari
structureif
sirna
antisens
strand
give
neg
valu
examin
structur
use
sirna
show
stemloop
structur
nucleotid
free
terminu
free
nucleotid
terminu
analys
sirna
meet
indic
criteria
first
check
anoth
partial
sequenc
viru
target
altern
threshold
local
rna
target
site
adjust
especi
mani
sirna
remain
whose
antisens
strand
form
stabl
secondari
structur
see
also
note
end
select
least
four
sirna
order
local
valu
threshold
reynold
criteria
changedin
gener
best
includ
partial
target
rna
length
kb
span
sirna
target
sequenceboth
extend
protocol
troubl
shout
guid
topo
clone
found
complet
instruct
manual
provid
kitfor
long
viru
target
sequenc
use
polymeras
proofread
activ
sinc
amplifi
sequenc
lack
aoverhang
essenti
describ
clone
method
addit
incub
taq
polymeras
necessaryif
e
coli
transform
electropor
salt
solut
must
dilut
fourfold
final
concentr
mm
nacl
mm
prevent
arcingopt
mm
ad
chemic
compet
e
coli
cell
follow
incub
ice
min
procedur
may
increas
transform
effici
store
mm
solut
map
sequenc
avail
invitrogen
websit
see
tabl
vector
map
sequenc
avail
promega
websit
see
tabl
restrict
site
may
also
suitabl
case
custom
addit
base
effici
restrict
incub
time
extens
tabl
provid
new
england
biolab
see
tabl
use
cell
line
orand
transfect
reagent
requir
differ
condit
given
heredens
sdspolyacrylamid
gel
depend
molecular
weight
mw
target
sequenc
use
add
mw
gfp
around
kd
calcul
mw
target
sequenc
estim
though
sequenc
may
influenc
gel
mobil
lead
measur
weight
predict
valuelarii
aliquot
thaw
room
temperatur
reagent
heatlabileincub
overnight
also
possibl
cell
plate
lower
densityan
moi
suitabl
mani
virus
case
may
need
adjust
control
infect
show
mani
individu
plaqu
reliabl
count
effect
sirna
appreci
reduc
number
plaqu
weak
sirna
may
lead
slight
reduct
larg
number
distinguish
plaqu
control
plate
simplifi
recognit
weak
sirna
may
desir
optim
possiblefc
within
medium
may
interfer
viral
infect
efficiencyincub
time
depend
infect
cycl
specif
virusneutr
red
well
crystal
violet
taken
healthi
cell
dead
cell
plaqu
therefor
appear
clear
circl
redviolet
background
clear
area
overlap
much
difficult
recogn
individu
plaqu
infect
time
reduc
plaqu
small
easili
read
tri
extend
infect
time
though
could
also
indic
defect
weaken
strainth
stain
acceler
use
crystal
violet
solut
end
fix
cell
tca
min
room
temperatur
remov
agar
without
disturb
cell
monolay
add
crystal
violet
solut
solut
pb
well
incub
min
room
temperatur
see
note
remov
stain
aspir
wash
pb
invert
plate
count
plaqu
well
calcul
viral
titer
describ
subhead
step
